arrow
K

Karl Kashofer

Medical University of Graz
H指数:39
被引数:6,381

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An Optimized Freeze-Dry Multimodal Workflow for Sequential Micro-CT Imaging, Histology, and Molecular Profiling: A Use Case in Human Liver Fibrosis

优化后的冷冻干燥多模态工作流程:用于序列显微CT成像、组织学及分子谱分析,以人类肝脏纤维化为应用案例

2026-08-290
OAAI
Idylla™ POLE-POLD1 mutation assay for molecular characterization and risk stratification of endometrial cancers: a retrospective multicenter validation study

Idylla™ POLE-POLD1突变检测试剂盒用于子宫内膜癌的分子特征分析和风险分层:一项回顾性多中心验证研究

2026-08-110
OA
Corrigendum to “CDKN2A Deletions but not Point Mutations May Explain Discordant Phenotype of Human Papilloma Virus (HPV) DNA–Positive and p16-Negative HPV-Associated Squamous Cell Carcinoma” (Modern Pathology. 2026 May;39(5):100994)

更正“CDKN2A缺失而非点突变可能解释人乳头瘤病毒(HPV)DNA阳性与p16阴性HPV相关鳞状细胞癌的不一致表型”(《现代病理学》2026年5月;39(5):100994)

2026-05-270
PRE
Functional footprints of homologous recombination deficiency in prostate cancer revealed by ctDNA fragmentation and transcription factor accessibility

同源重组缺陷的功能足迹:通过循环肿瘤DNA片段化和转录因子可及性在前列腺癌中的揭示

2026-01-090
OAAI
Standardization through education of molecular pathology: a spotlight on the European Masters in Molecular Pathology

通过分子病理学教育实现标准化: 聚焦欧洲分子病理学硕士

2024-10-021
PRE
Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe

欧洲胸部病理学实验室对非小细胞肺癌的真实世界EGFR测试实践

2023-10-0112
OAAI